Tailored education system to benefit kidney transplant patients

September 16, 2020

(LOS ANGELES) - Patients with chronic kidney disease and end-stage renal disease have to go to a dialysis center for hours at a time, several times a week for the rest of their lives. Patients on dialysis have strict dietary restrictions, and have difficulty maintaining a job or school with all of the hours that are spent at the dialysis center each week. Often, dialysis is the main treatment doctors tell patients about, so patients go along with it. However, a living donor kidney transplant is the most effective treatment for end-stage renal disease. Past research has shown that doctors typically spend about a half an hour giving patients large quantities of information all at once about transplantation, which causes patients to become overwhelmed with the decision.

The challenges of deciding how to manage kidney disease are even greater for low socioeconomic-status patients, or patients who speak a primary language other than English. To help overcome these challenges, and to help patients feel confident about making an informed choice in their kidney disease care, Dr. Waterman, Deputy Director at the Terasaki Institute for Biomedical Innovation, and colleagues developed a computerized program called "Your Path to Transplant" for patients. This program tailors education using an online quiz at four different time points to gauge patient knowledge and readiness to pursue transplant. The four time points were a few weeks before transplant evaluation, during transplant evaluation, and four and eight months after baseline. After the quiz at each time point, the program delivers the right education module to match patient knowledge and motivation at that point. The modules contain video and print kidney transplant education, feedback reports, access to community resources that help patients overcome socioeconomic barriers, and telephonic coaching. Breaking the education up into appropriate amounts of information in the modules at the right times in the patient journey can help to overcome the information overload and overwhelm that many patients feel when learning about their treatment options for managing their kidney disease.

In their recent publication titled "Your Path to Transplant: A Randomized Controlled Trial of a Tailored Expert System Intervention to Increase Knowledge, Attitudes and Pursuit of Kidney Transplant" in the American Journal of Transplantation, Dr. Waterman and colleagues tested their new program. The authors conducted a study at the University of California, Los Angeles Kidney and Pancreas Transplant Program on over 800 patients with end-stage kidney disease.

Results showed that patients who received the "Your Path to Transplant" education were significantly more prepared to pursue kidney transplant at four and eight months after the intervention compared to those who received standard of care. They also had a significantly greater increase in transplant knowledge compared to those who received standard of care. Those who received "Your Path to Transplant" took more small steps toward transplant, including sharing their need for a living donor, sharing educational materials about living donation, and asking potential donors to get tested for their ability to donate. Overall, 18 months later, more people who received the "Your Path to Transplant" education program received a living donor transplant, compared to those who received standard of care.

The authors state that this was "one of the longest and most comprehensive educational interventions ever to occur within a transplant center." The findings suggest that tailored education is successful in increasing knowledge and readiness to pursue transplant and should be embedded within centers to meet patients' educational needs as they navigate the challenging Path to Transplant.
Additional authors on this article include John D. Peirpert, PhD, Yujie Cui, MS, Jennifer L. Beaumont, MS, Andrea Pavia, PhD, Amanda F. Lipsey, MFA, Crystal S. Anderson, MPH, and Mark L. Robbins, PhD. Financial support came from the National Institutes of Health under grants R01DK088711 and T32DK104687.


Stewart Han, shan@terasaki.org, +1 818-836-4393

Terasaki Institute for Biomedical Innovation

The Terasaki Institute for Biomedical Innovation (terasaki.org) is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. Research at the Terasaki Institute leverages scientific advancements that enable an understanding of what makes each person unique, from the macroscale of human tissues down to the microscale of genes, to create technological solutions for some of the most pressing medical problems of our time. We use innovative technology platforms to study human disease on the level of individual patients by incorporating advanced computational and tissue-engineering methods. Findings yielded by these studies are translated by our research teams into tailored diagnostic and therapeutic approaches encompassing personalized materials, cells and implants with unique potential and broad applicability to a variety of diseases, disorders and injuries.

The Institute is made possible through an endowment from the late Dr. Paul I. Terasaki, a pioneer in the field of organ transplant technology.

Terasaki Institute for Biomedical Innovation

Related Kidney Disease Articles from Brightsurf:

Waistline matters in kidney disease
Does fat matter in kidney disease? The investigators found that all measures of higher abdominal fat content (including visceral fat, liver fat, or subcutaneous fat) and slower walk times were associated with increased levels of cardiometabolic risk factors in adults with non-dialysis dependent kidney disease.

Reducing urinary protein for patients with rare kidney disease slows kidney decline
New findings show that reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis can significantly slow declines in kidney function and extend time before patients' kidneys fail.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Acute kidney injury and end stage kidney disease in severe COVID-19
Many COVID-19 patients experience hematuria, proteinuria and elevated serum creatinine concentration early in the course of the disease.

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

A healthy diet may help prevent kidney disease
In an analysis of published studies, a healthy dietary pattern was associated with a 30% lower incidence of chronic kidney disease.

Is kidney failure a man's disease?
A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.

Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.

Read More: Kidney Disease News and Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.